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COMORBIDITIES IN DRIVERS WITH PARKINSON DISEASE 
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Summary: Previous studies have shown that comorbidities have an impact on 
driving performance in older adults. No study has established the relationships 
between comorbidities and driving in persons with Parkinson disease (PD). The 
aims of this study were (1) to report the types of comorbidity in a group of 111 
drivers with PD and (2) to identify whether the comorbidity associated with PD is 
a predictor of overall fitness-to-drive decisions, crashes, and validity duration of 
driving license. Results showed that 72 participants (64.9%) had only Parkinson 
disease, and 39 (35.1%) participants had one or more medical conditions in addition 
to PD. The most frequent comorbidities were visual disorders (26.4%), heart and 
blood disorders (16.2%), neurological disorders other than PD (11.8%), and 
locomotor disorders (11.8%). Contrarily to what we expected, we did not find any 
significant associations between comorbidities and overall fitness-to-drive 
decisions, car crashes, or validity duration of driving license. We conclude that in 
this sample of drivers with PD, comorbidity was not a significant predictor of 
overall fitness-to-drive decisions. 
 
INTRODUCTION 
 
Mobility is an important activity of daily living that affects physical, emotional, and social well-
being (James et al., 2011). In broad terms, mobility is the purposeful movement through the 
environment and spans a continuum from total immobility (e.g., bed-ridden) to travels to distant 
locations (Ross et al., 2013).  
 
Comorbidity, which is defined as the presence of one or more additional disorders co-occurring 
with a primary disease (Valderas et al., 2009), can have serious implications on mobility. A 
variety of comorbid conditions, such as eye disease, heart disease, and fatigue are related to 
mobility limitations in older adults (Popescu et al., 2011; Yeom et al., 2008). These comorbid 
conditions may impact gait, balance, but also other modes of mobility such as driving (Papa et 
al., 2014; Popescu et al., 2011). The age-related changes in brain, musculoskeletal, visual, and 
auditory functions may be exacerbated when occurring concurrently with Parkinson disease (PD) 
(King et al., 2014; Sagna et al., 2014). PD is a progressive neurological condition characterized 
by motor and non-motor symptoms which may adversely affect driving performance (Devos et 
al., 2013; Ranchet et al., 2013; Uc et al., 2009).  
 
A recent study reported a high frequency of comorbidities in people with mild to moderate PD 
(King et al., 2014). King et al. (2014) found eyes and ears (89%), psychiatric (68%), 
musculoskeletal (64%), lower gastrointestinal (62%), respiratory (60.5%), upper gastrointestinal 
(59.2%) and genitourinary (53.9%) conditions to be most frequently reported in association with 
PD. Visser et al. (2004) reported that 84% of patients with PD had one or more comorbidities 
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such as lower gastrointestinal (55%), genitourinary (52%), musculoskeletal (48%) and eyes, ears, 
throat, and larynx (48%) diseases. The frequency of comorbidity was significantly related to 
measures of mobility including gait, balance, and physical function (King et al., 2014). To date, 
the relationship between comorbidities and fitness-to-drive decisions, car crashes, and other 
driving measures remains unclear. 
 
The aims of this study were (1) to report the types of comorbidities in a group of drivers with PD 
and (2) to identify whether the comorbidities associated with PD are related to overall fitness-to-
drive decisions, car crashes, and validity duration of driving license. 
 
METHODS 
 
Population 
 
Recruitment and eligibility. The data of all clients who were evaluated at the Center of 
Evaluation of Fitness to drive and Car Adaptations (CARA) of the Belgian Road Safety Institute 
in the period January to December 2013 were reviewed for eligibility. Clients were included if 
(1) they were diagnosed with Parkinson’s disease; (2) had a valid driver’s license; (3) and met 
the minimum visual acuity requirements of fitness to drive in Belgium (20/40 binocular acuity).  
The comorbidity was recorded by the referring physician and categorized into 12 groups: (1) 
neurological condition other than PD (e.g., dementia, stroke…); (2) locomotor disorders; (3) 
visual dysfunction; (4) heart and blood disorders; (5) mental disorders; (6) epilepsy; (7) diabetes; 
(8) psychotropic substance abuse; (9) vestibular system disorders; (10) implants; (11) renal and 
hepatic impairment; and (12) pathological somnolence. This study was approved by the Georgia 
Regents University Institutional Review Board (IRB-A). 
 
Outcome variables 
 
Overall fitness-to-drive decision. The overall fitness-to-drive evaluation performed at CARA 
included a review of the medical history, an assessment of visual functions and on-road driving 
skills, and if needed, a neuropsychological evaluation. After the CARA evaluation, participants 
were categorized as pass when they were “fit to drive without restrictions” or “fit to drive with 
restrictions” (i.e. restricted use in time, distance or speed) and categorized as fail when they were 
“unfit to drive”. Fifty-four patients (48.6%) came to CARA for an extension of the drivers’ 
license validity period, 50 (45.0%) because of change in medical situation, 2 (1.8%) were 
referred by their insurance company or a medical expert) and 5 (4.5%) for unknown reasons.  
Car crashes. Participants were asked if they were involved in a car crash in the five years prior 
to the CARA evaluation (dichotomous variable: “yes” or “no”). 
Validity duration of driver’s license. This variable was calculated as the difference between the 
allocated expiration date of the driving license and date of assessment. 
 
Data analysis  
 
To investigate the effect of comorbidities on overall fitness-to-drive decisions, car crashes, and 
the validity duration of the driver’s license in PD, participants were divided in 2 groups: (1) 
people with PD only and (2) people with PD and one or more medical conditions. Univariate 
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Analysis of Variance (ANOVA) was used to compare age between the 2 groups. Chi2 was used 
for categorical variables to determine associations between comorbidities and overall fitness-to-
drive decisions or car crashes. Spearman correlations were performed between the number of 
comorbidities and the validity duration of driver’s license. Binomial logistic regression or linear 
regression analyses were used to investigate whether comorbidities are predictors of overall 
fitness-to-drive decisions, car crashes, and validity duration of driver’s license. P values ≤ 0.05 
were applied to all our statistical analyses. All analyses were performed with SPSS 21.0 
statistical software.  
 
RESULTS  
 
Population  
 
One hundred eleven (111) clients were PD (91 men/ 20 women) were evaluated by CARA. The 
mean age was 68.05 ± 10.92 years, with a range from 35 to 96 years. Among 98 participants, 64 
(65.3%) were declared “fit to drive without restrictions”, 20 were (20.4%) “fit to drive with 
restrictions” and 14 (14.3%) were “unfit to drive” (missing variables: n = 13). Eighteen patients 
(16.2%) reported having one or more crashes in the 5 years prior to testing and 76 (68.4 %) 
reported no crashes. Seventeen (15.3%) did not report information with regard to car crashes.  
 
Frequency and types of comorbidity in drivers with PD 
 
Seventy-two people (64.9%) had only PD and 39 (35.1%) people had 1 or more comorbidities in 
addition to PD. An increased number of comorbidities was associated with a reduced number of 
people (Chi2 = 49.7, p < 0.001). No significant differences in terms of age between the 2 groups 
were found (PD group: 67.1 ± 11.1 years; PD group + 1 or more medical condition: 69.8 ± 10.5, 
F = 1.5, p = 0.2). Figure 1 shows the percentage of drivers with one medical condition in 
addition to PD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Percentage of drivers with another type of medical condition than PD 
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The four most frequent medical conditions reported in this sample were visual disorders (n = 18, 
26.5%), heart and blood disorders (n = 11, 16.2%), neurological disorders other than PD (n = 8, 
11.8%), and locomotor disorders (n = 8, 11.8%), followed by diabetes (n = 6, 8.8%), mental 
disorders (n = 5, 7.4%), pathological somnolence (n = 4, 5.9%), implants (n = 4, 5.8%), 
vestibular system disorders (n = 1, 1.5%), renal and hepatic impairments (n = 1, 1.5%), 
psychotropic substance abuse (n = 1, 1.5%), and epilepsy (n = 1, 1.5%). 
 
Relationships between comorbidities and fitness-to-drive decisions, car crashes, and 
validity duration of the driving license in PD patients 
 
No significant associations were found between comorbidities and fitness-to-drive decisions 
(Chi2 = 0.03, p = 0.86) and car crashes (Chi2 = 0.50, p = 0.48) (Table 1 and Table 2, 
respectively).  
 
Table 1. Association between comorbidities and overall fitness-to-drive decisions 
   Overall fitness-to-drive decisions   
   Pass Fail p 
only PD 56 (86.2%) 9 (13.8%) 
0.86 
1 or more additional medical conditions 28 (84.8%) 5 (15.2%) 
 
Table 2. Association between comorbidities and car crashes 
   Car crashes   
   No Yes p 
only PD 49 (83.1%) 10 (16.9%) 
0.48 
1 or more additional medical conditions 27 (71.4%) 8 (22.9%) 
 
Similarly, comorbidities did not predict overall fitness-to-drive decisions (B = 0.11, Odds Ratio 
(OR) = 1.11, CI 95%: 0.34 - 3.63, p = 0.86) and car crashes (B = 0.37, OR = 1.452, CI 95%: 0.51 
- 4.11, p = 0.48) in the logistic regression analysis (n = 98). 
 
No significant correlation was found between the number of comorbidities and driving license 
duration (rho = -0.02, p=0.87). Furthermore, comorbidities did not predict the validity duration 
of driver’s license in the linear regression model (B = -36.3, CI 95%: -210.56 -137.92, p = 0.68).  
 
DISCUSSION 
 
The main objective of this study was to identify whether comorbidities are related to overall 
fitness-to-drive decisions, self-reported car crashes and validity duration of the driver’s license in 
a sample of 111 PD people evaluated by CARA in 2013. The interest of using a population-
based approach was to include a heterogeneous group of drivers with PD who have one or more 
comorbidities, which are often considered an exclusion criterion in most studies on driving and 
PD (Classen et al., 2014; Devos et al., 2007; Ranchet et al., 2013; Uc et al., 2009). Consequently, 
it is often difficult to generalize the findings to the population of drivers with PD who often 
experience age-related comorbidities. Several studies have shown comorbidities as predictor of 
PROCEEDINGS of the Eighth International Driving Symposium on Human Factors in Driver Assessment, Training and Vehicle Design 
47 
driving performance, driving pattern and crash involvement in older adults (Papa et al., 2014) or 
in individuals with neurological conditions (Devos et al., 2010). For instance, Devos et al. (2010) 
showed that patients who gave up driving in the five years after their stroke had more 
comorbidity than those who were still driving. However, no study has specifically explored the 
impact of comorbidities on driving measures in a group of active drivers with PD.  
 
The most frequent medical conditions in our sample were visual disorders (26.5%), heart and 
blood disorders (16.2%), neurological disorders other than PD (11.8%) and locomotor disorders 
(11.8%), which is in accordance with the type of comorbidity reported in the literature (King et 
al., 2014; Visser et al., 2004). Deficit in visual functions and heart and blood disorders are 
common among elderly people and may be exacerbated by PD. Yet, compared with previous 
studies (King et al., 2014; Visser et al., 2004), the proportion of people with PD having 
comorbidities in this sample (35.1%) was relatively low. The participants in this study are still 
active drivers and may have presented with a better clinical picture than those in previous studies 
(King et al., 2014; Visser et al., 2004). Another reason may be that physicians only reported 
comorbidity that was expected to impact safe driving. Comorbidities related to the gastro-
intestinal system, genitourinary system, and throat and larynx diseases, which are frequently 
observed in PD (King et al., 2014), may have been underreported in our sample of drivers with 
PD. 
 
Contrary to what we expected, we did not find any significant associations between 
comorbidities and overall fitness-to-drive decisions. The lack of significant results might be due 
to the binary measure of driving safety (pass/fail). Similarly, no significant associations were 
found between comorbidities and self-reported car crashes, and validity duration of the driver’s 
license, which may be due to the small number of PD drivers having one or more comorbidities. 
As previously said, this number is relatively low compared to other studies in PD people (King et 
al., 2014; Visser et al., 2004). Another reason might be that comorbidities associated with our PD 
group were not severe enough to have an impact on the driving outcomes measures in our study. 
In the study of King et al. (2014), 60% of PD people reported mild complaints of eyes and ears 
whereas 43% reported severe psychiatric comorbidity. The severity of the comorbidities was 
significantly associated with mobility measures. Further studies with larger sample sizes that 
take into account severity indices of comorbidity are therefore warranted.  
 
Conclusions  
 
Most studies on driving and PD have used stringent eligibility criteria, which make it difficult to 
generalize their findings to the population of drivers with PD. The current study used a cohort of 
community-dwelling drivers with PD to explore the associations between comorbidity and 
driving. In this sample, we did not find that comorbidity was a significant predictor of overall 
fitness-to-drive decisions, car crashes and validity duration of the driver’s license. Further 
investigation will explore the impact of comorbidities on driving safety in PD.  
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